ASCO 2017: Survival impact of initial local therapy selection for men under 60 with high risk prostate cancer

The impact of initial local therapy selection on survival for high risk prostate cancer patients remains uncertain, particularly in younger men who in general have an appropriate life-expectancy at the time of prostate cancer diagnosis. Dr. Kaiser and colleagues presented their results of a study assessing the impact of initial local therapy selection for men under 60 with high risk prostate cancer at the prostate cancer poster sessions at the 2017 ASCO annual meeting.
Uro Today